Sleeve Lobectomy After Neoadjuvant Chemoimmunotherapy Versus Chemotherapy for Squamous Cell Lung Cancer: A Multicenter, Retrospective Study

Sleeve Lobectomy After Neoadjuvant Chemoimmunotherapy Versus Chemotherapy for Squamous Cell Lung Cancer: A Multicenter, Retrospective Study

Introduction: To analyze the feasibility and efficacy of sleeve lobectomy after neoadjuvant immunotherapy in multicenter patients with squamous cell lung cancer. Methods: We retrospectively identified patients who received neoadjuvant immunotherapy (n = 14) or chemotherapy alone (n = 33) at five tho...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Tianxiang Chen, MD, PhD, Junwei Ning, MD, Jianfei Shen, MD, PhD, Hui Pan, MD, Linhai Fu, MD, Enwu Xu, MD, PhD, Han Wu, MD, Jia Huang, MD, PhD, Yunhai Yang, MD, PhD, Ziming Li, MD, PhD, Qingquan Luo, MD, PhD
Formaat: Artikel
Taal:English
Gepubliceerd in: Elsevier 2023-04-01
Reeks:JTO Clinical and Research Reports
Onderwerpen:
Neoadjuvant therapy
Sleeve lobectomy
Squamous cell lung cancer
PD-1 inhibitor
Online toegang:http://www.sciencedirect.com/science/article/pii/S2666364323000115

Internet

http://www.sciencedirect.com/science/article/pii/S2666364323000115

Gelijkaardige items